View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Study - GMMG-HD 6 - Lenalidomide 15 / Dexamethasone 12 / Elotuzumab 10, Multiple Myeloma, Maintenance Cycle 7+
Protocol-ID: 1093 V1.1 (Mini), STUDY-GMMG-HD6 - LENA15/DEXA12/ELOT10, MM, maint. A2 + B2, C7+Study protocol, available to authorized participants only.
Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 10.03.2020